Savara (SVRA) Total Liabilities (2010 - 2026)
Savara (SVRA) reported Total Liabilities of $45.6 million for Q1 2026, up 9.98% year-over-year from $41.5 million in Q1 2025, and down 9.34% quarter-over-quarter from $50.3 million in Q4 2025.
Savara (SVRA) Total Liabilities (2010 - 2026) Analysis & Trends
Savara (SVRA) has 17 years of Total Liabilities data on file, last reported at $45.6 million in Q1 2026.
- Total Liabilities for Q1 2026 came in at $45.6 million, up 9.98% year-over-year; the trailing twelve-month figure through Mar 2026 was $45.6 million (up 9.98% YoY), and the FY2025 annual result was $50.3 million, up 21.42% from the prior year.
- Total Liabilities retreated to $45.6 million in Q1 2026 per SVRA's latest filing, from $50.3 million in the prior quarter.
- Over five years, Total Liabilities peaked at $50.3 million in Q4 2025 and troughed at $29.7 million in Q1 2022.
- A 5-year average of $37.7 million and a median of $37.2 million in 2023 frame the typical range for Total Liabilities.
- The sharpest annual moves came in 2022 and 2025: Total Liabilities decreased 8.54% in 2022, then advanced 21.42% in 2025.
- A 5-year view of Total Liabilities shows it stood at $32.0 million in 2022, then advanced by 16.23% to $37.2 million in 2023, then increased by 11.39% to $41.4 million in 2024, then increased by 21.42% to $50.3 million in 2025, then retreated by 9.34% to $45.6 million in 2026.
- Business Quant data shows SVRA's Total Liabilities at $45.6 million in Q1 2026, $50.3 million in Q4 2025, and $46.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1.74 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 15.48 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 16.35 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 731.60 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 10.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 19.51 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 943,068.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 7.12 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 137.56 Mn |
| 10 | Savara | 1.39 Bn | 1.39 Bn | - | 45.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 45.61 Mn |
| Dec 31, 2025 | 50.30 Mn |
| Sep 30, 2025 | 46.54 Mn |
| Jun 30, 2025 | 43.28 Mn |
| Mar 31, 2025 | 41.47 Mn |
| Dec 31, 2024 | 41.43 Mn |
| Sep 30, 2024 | 39.47 Mn |
| Jun 30, 2024 | 37.94 Mn |
| Mar 31, 2024 | 36.43 Mn |
| Dec 31, 2023 | 37.19 Mn |
| Sep 30, 2023 | 35.53 Mn |
| Jun 30, 2023 | 32.12 Mn |
| Mar 31, 2023 | 31.10 Mn |
| Dec 31, 2022 | 32.00 Mn |
| Sep 30, 2022 | 31.24 Mn |
| Jun 30, 2022 | 29.74 Mn |
| Mar 31, 2022 | 29.73 Mn |
| Dec 31, 2021 | 32.10 Mn |
| Sep 30, 2021 | 32.05 Mn |
| Jun 30, 2021 | 31.05 Mn |